Tampa, FL, United States of America

Michael J Mullan

USPTO Granted Patents = 16 


 

Average Co-Inventor Count = 1.9

ph-index = 4

Forward Citations = 158(Granted Patents)


Location History:

  • Tampa Palms, FL (US) (2000 - 2009)
  • Bradenton, FL (US) (2010)
  • Tampa, FL (US) (1995 - 2011)
  • Sarasota, FL (US) (2012)

Company Filing History:


Years Active: 1995-2012

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Michael J Mullan: Innovator in Alzheimer's Research

Introduction

Michael J Mullan is a prominent inventor based in Tampa, FL, known for his significant contributions to the field of Alzheimer's research. With a total of 16 patents to his name, Mullan has dedicated his career to developing innovative solutions for combating cerebral amyloidogenic diseases.

Latest Patents

Mullan's latest patents focus on pharmaceutical compositions aimed at reducing amyloid deposition, neurotoxicity, and microgliosis. One of his notable inventions involves the use of the (R)-enantiomer of the dihydropyridine compound nilvadipine, also known as (−)-nilvadipine. This invention provides methods for administering therapeutically effective amounts of nilvadipine to individuals afflicted with Alzheimer's disease, thereby reducing the risk of amyloid deposition and neurotoxicity. Additionally, Mullan's work includes methods for treating traumatic brain injury by administering nilvadipine post-injury and continuing treatment for a prescribed duration.

Career Highlights

Throughout his career, Mullan has worked with esteemed organizations such as the Alzheimer's Institute of America, Inc. and the University of South Florida. His research has significantly advanced the understanding of Alzheimer's disease and has contributed to the development of potential therapeutic interventions.

Collaborations

Mullan has collaborated with notable colleagues in the field, including Daniel Paris and John Anthony Hardy. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions for Alzheimer's disease.

Conclusion

Michael J Mullan's work exemplifies the impact of innovation in the medical field, particularly in the fight against Alzheimer's disease. His dedication to research and development continues to pave the way for new therapeutic approaches that may improve the lives of those affected by this challenging condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…